OmniAb, Inc. (OABI)
4.945
+0.34
(+7.27%)
USD |
NASDAQ |
Oct 27, 16:00
4.945
0.00 (0.00%)
After-Hours: 18:23
OmniAb Enterprise Value : 637.17M for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 637.17M |
| October 23, 2026 | 644.44M |
| October 22, 2026 | 661.88M |
| October 21, 2026 | 681.51M |
| October 20, 2026 | 688.05M |
| October 19, 2026 | 648.80M |
| October 16, 2026 | 634.26M |
| October 15, 2026 | 654.61M |
| October 14, 2026 | 628.44M |
| October 13, 2026 | 650.25M |
| October 12, 2026 | 660.43M |
| October 09, 2026 | 663.34M |
| October 08, 2026 | 644.44M |
| October 07, 2026 | 629.90M |
| October 06, 2026 | 599.37M |
| October 05, 2026 | 682.24M |
| October 02, 2026 | 674.97M |
| October 01, 2026 | 692.42M |
| September 30, 2026 | 688.05M |
| September 29, 2026 | 656.07M |
| September 28, 2026 | 656.07M |
| September 25, 2026 | 637.17M |
| September 24, 2026 | 663.34M |
| September 23, 2026 | 663.34M |
| September 22, 2026 | 682.24M |
| Date | Value |
|---|---|
| September 21, 2026 | 632.81M |
| September 18, 2026 | 616.81M |
| September 17, 2026 | 612.45M |
| September 16, 2026 | 599.37M |
| September 15, 2026 | 599.37M |
| September 14, 2026 | 618.27M |
| September 11, 2026 | 558.66M |
| September 10, 2026 | 541.21M |
| September 09, 2026 | 550.66M |
| September 08, 2026 | 583.37M |
| September 04, 2026 | 596.46M |
| September 03, 2026 | 657.52M |
| September 02, 2026 | 699.69M |
| September 01, 2026 | 612.45M |
| August 31, 2026 | 603.73M |
| August 28, 2026 | 616.81M |
| August 27, 2026 | 637.17M |
| August 26, 2026 | 666.25M |
| August 25, 2026 | 644.44M |
| August 24, 2026 | 651.71M |
| August 21, 2026 | 596.46M |
| August 20, 2026 | 592.10M |
| August 19, 2026 | 576.10M |
| August 18, 2026 | 536.85M |
| August 17, 2026 | 522.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 59.33B |
| Champions Oncology, Inc. | 74.82M |
| Medpace Holdings, Inc. | 18.35B |
| Charles River Laboratories International, Inc. | 19.92B |
| Avantor, Inc. | 15.09B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.859M |
| Revenue (Quarterly) | 13.42M |
| Total Expenses (Quarterly) | 19.27M |
| EPS Diluted (Quarterly) | -0.0455 |
| Gross Profit Margin (Quarterly) | 64.01% |
| Profit Margin (Quarterly) | -43.68% |
| Earnings Yield | -7.29% |
| Normalized Earnings Yield | -7.383 |